Prevention of atrial fibrillation
284 results
1 - 100
Prevention of atrial fibrillation - Dronedarone in the prevention of atrial fibrillation - Image
Interventions for preventing post‐operative atrial fibrillation in patients undergoing heart surgery
Low-dose edoxaban effective for stroke prevention for elderly patients with atrial fibrillation- Angiotensin receptor blockers or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation
- Warfarin for preventing stroke in patients with non-valvular atrial fibrillation and no history of cerebral ischaemia
- Warfarin or antiplatelet therapy for stroke prevention in patients with non-valvular atrial fibrillation
- Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack
- Oral anticoagulants for preventing stroke in patients with non‐valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
- Screening high-risk patients for atrial fibrillation with implantable loop recorder does not prevent stroke or systemic emboli (LOOP)
- Factor Xa inhibitors versus vitamin K antagonists for preventing embolism in patients with atrial fibrillation
- For atrial fibrillation with stable coronary artery disease, edoxaban alone prevents more bad outcomes than edoxaban plus an antiplatelet agent
- For patients with subclinical intermittent atrial fibrillation, apixaban prevents 1 stroke and causes 1 major bleed per 250 persons (ARTESIA)
- Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack: Cochrane systematic review
- Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
- Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non‐valvular atrial fibrillation
- Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane systematic review
- Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks: Cochrane systematic review
- Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Management of acute atrial fibrillation
- ARBs & ACE inhibitors prevent A fib
- Treatment approach for atrial fibrillation: rate control or rhythm control?
- Warfarin therapy
- Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter: Cochrane systematic review
- Atrial fibrillation recurrence higher with episodic treatment with amiodarone
- Antiplatelet therapy for patients with non-valvular atrial fibrillation
- Cryoablation preferred as initial therapy for paroxysmal atrial fibrillation (EARLY-AF)
- USPSTF 2022 concludes evidence is insufficient to recommend screening for asymptomatic atrial fibrillation (I statement)
- Rhythm control is associated with a lower risk of cognitive decline than rate control in adults with atrial fibrillation
- Direct oral anticoagulants versus vitamin K antangonists in non-valvular atrial fibrillation
- Choice of prophylactic medication for atrial fibrillation - Image
- Older patients with atrial fibrillation treated with DOACs have fewer strokes and systemic emboli than those treated with vitamin K antagonists
- The DOAC score determines bleeding risk for patients with atrial fibrillation who take a direct-acting oral anticoagulant
- Dronedarone reduces hospitalization but not mortality in atrial fibrillation
- Anticoagulants for non-rheumatic atrial fibrillation and a history of stroke or transient ischaemic attacks